Timeline on Global Health Norm setting on non-communicable diseases


  • May 20, 2000 – WHO passes WHA 53.17, which calls for research, prevention, collaboration, and capacity building to prevent and control noncommunicable diseases


  • April 13, 2002 –The Salt Institute and other industry lobbying groups release their first comments on the DASH trials and otherwise attack and attempt to undermine the independent WHO/FAO expert report on Diet, Nutrition and the Prevention of Chronic Diseases, which calls for salt reduction as a means to reduce the risk of hypertension and proposes limiting free sugar intake as a means to reduce the risk of diabetes.
  • May 18, 2002 – WHO passes WHA 55.23, which mandates that WHO develop a Global Strategy on Diet, Physical Activity, and Health





  • February 8, 2007 – Derek Yach, former Executive Director of the Noncommunicable Diseases and Mental Health cluster at the World Health Organization (WHO), is appointed as PepsiCo’s Director of Global Health Policy
  • March 2, 2007 – KEI sends its Letter to WHO on the Essential Medicines List, outlining potentially essential medicines “if available from competitive generic suppliers at generic prices,” including several NCD medicines.
  • September 15, 2007 – Caribbean states (CARICOM) hold a summit on NCDs that eventually compels CARICOM to support the UN General Assembly Resolution calling for a high-level meeting in 2011.




  • May 20, 2010 – UN General Assembly Resolution 64/265 formally approves the 2011 UN High Level Summit on NCDs
  • September 17, 2010 – The NCD Alliance announces its Plan of Action for the 2011 UN Summit on NCDs
  • September 24, 2010 – Medtronic Foundation, the corporate foundation of a major manufacturer of insulin pumps for diabetes, announces announces a $1M commitment to the NCD Alliance and its partners to support advocacy leading up to the 2011 UN High Level Meeting on NCDs.

    The Medtronic Foundation commits to invest $1 million to support the Non-Communicable Diseases Alliance and its partners in order to ensure a productive and results-driven UN General Assembly Special Session on Non-Communicable Diseases, or NCDs, in 2011. The Foundation will invest in the World Heart Federation and the International Diabetes Federation, both NCD Alliance members, to help them develop key planning and advocacy activities, including a set of specific goals for the UN, in order to make these types of disease a global health priority.


  • February 24-25, 2011 – PAHO Regional Meeting on NCDs in Mexico City
  • March 14-17, 2011 – WHO / UNDESA UN Summit Regional Member States Consultation at the SEARO Regional Meeting on Health And Development Challenges of Noncommunicable Diseases (NCD) in Dhaka
  • March 25-27, 2011 – WHO WPRO NCD Consultation, Seoul
  • June 13-17, 2011 – The Global Health Council’s Annual Conference in Washington, DC will focus on NCDs
  • September 19-20, 2011 – High-level Meeting of the United Nations General Assembly on the Prevention and Control of Noncommunicable Diseases in New York